GeneThera, Inc.
OTC: GTHR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Antonio Milici
- Employees
- 2
- Headquarters
- Westminster, United States
- IPO year
- 2012
- Market cap
- $3.5K
- Website
- https://www.genethera.net
Loading GTHR…
Loading profile data…Frequently asked questions about GTHR
What does GeneThera, Inc. (GTHR) do?
GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced diagnostic tools and therapeutic solutions for diseases that can transfer from animals to humans (zoonotic diseases). The company's portfolio includes treatments for a variety of these conditions, such as COVID-19, and illnesses like paratuberculosis (Johne's disease), curren...
Where does GTHR trade?
GeneThera, Inc. (GTHR) trades on the Other OTC.
What sector is GTHR in?
GeneThera, Inc. (GTHR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of GeneThera, Inc.?
Antonio Milici is the chief executive officer of GeneThera, Inc. (GTHR).
Where is GeneThera, Inc. headquartered?
GeneThera, Inc. is headquartered in United States.
Does GTHR pay a dividend?
GeneThera, Inc. (GTHR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GTHR go public?
GeneThera, Inc. (GTHR) completed its initial public offering in 2012.